The fertility industry: profiting from vulnerability
By Editorial Staff,
The Lancet
| 07. 20. 2024
Image by DrKontogianniIVF from Wikimedia Commons
Despite major advances in securing sexual and reproductive rights globally, one aspect is continually neglected: infertility. Evolving gender norms and financial precariousness have led to delayed childbearing, which increases infertility in both males and females. An estimated one in six people are affected. However, there is insufficient awareness about fertility decline, the risk factors, and viable treatments for infertility. Assisted reproductive technologies (ARTs), particularly in-vitro fertilisation (IVF), help many. Almost 50 years after the birth of the first baby conceived by IVF was reported in The Lancet, this method is used in 9% of births in some high-income countries. Such advances have enabled millions to have children. However, the fertility sector has now spawned an entire industry that risks exacerbating rather than alleviating the psychological toll of infertility and does little to help reduce inequities in access to quality care.
Medical advances have helped increase the effectiveness of IVF. In women aged 35–37 years in the UK, the livebirth rate per embryo transferred increased from 6% in 1991 to 25% in 2019...
Related Articles
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Margaux MacColl, The San Francisco Standard | 09.17.2025
Designer babies are coming soon to an IVF clinic near you.
Nucleus Genomics, founded by Kian Sadeghi in 2020, when he was just 20, got its start analyzing genomes to weigh a person’s risk of everything from cancer to ADHD...
By Marianne Lamers, NEMO Kennislink [cites CGS' Katie Hasson] | 09.23.2025
Een rijtje gespreide vulva’s gaapt de bezoeker aan. Zó ziet een bevalling eruit, en zó een baarmoeder met foetus. Een zwangerschap, maar dan zonder zwangere vrouw, gestript van zorgen, gêne en pijn. De zwangerschapsmodellen en oefenbekkens, te zien in de...